Victory Capital Management Inc. Acquires 95,706 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

Victory Capital Management Inc. lifted its position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 748.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 108,497 shares of the company's stock after buying an additional 95,706 shares during the quarter. Victory Capital Management Inc. owned about 0.28% of Viemed Healthcare worth $795,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. lifted its stake in Viemed Healthcare by 53.0% in the first quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company's stock valued at $16,803,000 after buying an additional 617,009 shares during the period. Renaissance Technologies LLC increased its stake in shares of Viemed Healthcare by 50.9% in the 2nd quarter. Renaissance Technologies LLC now owns 438,700 shares of the company's stock valued at $2,873,000 after acquiring an additional 147,900 shares in the last quarter. Paradigm Capital Management Inc. NY lifted its position in shares of Viemed Healthcare by 25.0% during the 2nd quarter. Paradigm Capital Management Inc. NY now owns 400,000 shares of the company's stock valued at $2,620,000 after acquiring an additional 80,000 shares during the period. Raffles Associates LP boosted its stake in Viemed Healthcare by 4.3% during the second quarter. Raffles Associates LP now owns 362,691 shares of the company's stock worth $2,376,000 after acquiring an additional 15,000 shares in the last quarter. Finally, Panagora Asset Management Inc. grew its holdings in Viemed Healthcare by 1.1% in the second quarter. Panagora Asset Management Inc. now owns 272,383 shares of the company's stock worth $1,784,000 after purchasing an additional 2,904 shares during the period. Institutional investors own 74.24% of the company's stock.

Insider Buying and Selling

In other Viemed Healthcare news, Director Nitin Kaushal sold 30,000 shares of the stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $9.56, for a total value of $286,800.00. Following the completion of the sale, the director now owns 126,843 shares in the company, valued at approximately $1,212,619.08. This trade represents a 19.13 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Randy E. Dobbs sold 36,261 shares of the business's stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total value of $336,502.08. Following the completion of the transaction, the director now owns 107,706 shares in the company, valued at $999,511.68. The trade was a 25.19 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 72,256 shares of company stock worth $674,739. 20.00% of the stock is owned by corporate insiders.

Viemed Healthcare Stock Up 1.3 %

VMD stock traded up $0.11 during trading on Friday, reaching $8.67. 64,502 shares of the stock were exchanged, compared to its average volume of 152,917. The firm's 50 day moving average is $8.61 and its 200 day moving average is $7.60. The firm has a market cap of $337.61 million, a P/E ratio of 32.11 and a beta of 1.43. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. Viemed Healthcare, Inc. has a twelve month low of $6.21 and a twelve month high of $10.44.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.10 EPS for the quarter, beating analysts' consensus estimates of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The business had revenue of $58.00 million during the quarter.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.